28.10.2011

Majority Stake in CU Chemie Uetikon Sold to Barclays Private Equity

Barclays Private Equity (BPE) has acquired a majority shareholding in CU Chemie Uetikon, a fine chemicals company based in Lahr, Germany.  With a shareholding of 90%, BPE will have a controlling interest in the spin-off from the Swiss group CPH Chemie + Papier Holding AG. Together with management, BPE said it will pursue a consistent growth strategy in pharmaceuticals, cosmetics and nutrition industries. more21.06.2011

In Conversation with Dr. Heinz Sieger, CEO of CU Chemie Uetikon

CU Chemie Uetikon CEO Heinz Sieger spoke to CHEManager Europe Editor Brandi Schuster about what his customers are looking for when it comes to custom synthesis. Sieger is also active in industry groups such as the CASID, a society for custom synthesis in Germany, and the European Fine Chemicals Group (EFCG), which works to create a level playing field for European manufacturers of APIs and excipients. more28.05.2010

Time For Action

The German advertising tagline "greed is good" is now outmoded as a basic principle of purchasing. A low purchase price does not mean that a product is actually inexpensive. Therefore the saying, "Those who buy cheap buy twice" often applies. As it would seem, this commonplace insight for consumer goods also applies in the chemical and pharmaceutical industries. Quality obviously does not always correlate with price. more